- Home
- SILO vs EVGN Comparison
SILO vs EVGN Comparison
Compare SILO & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- EVGN
- Stock Information
- Founded
- SILO 2010
- EVGN 1999
- Country
- SILO United States
- EVGN Israel
- Employees
- SILO N/A
- EVGN N/A
- Industry
- SILO Apparel
- EVGN Agricultural Chemicals
- Sector
- SILO Consumer Discretionary
- EVGN Industrials
- Exchange
- SILO Nasdaq
- EVGN Nasdaq
- Market Cap
- SILO 8.8M
- EVGN 9.7M
- IPO Year
- SILO N/A
- EVGN N/A
- Fundamental
- Price
- SILO $1.08
- EVGN $1.27
- Analyst Decision
- SILO
- EVGN Strong Buy
- Analyst Count
- SILO 0
- EVGN 1
- Target Price
- SILO N/A
- EVGN $12.00
- AVG Volume (30 Days)
- SILO 139.6K
- EVGN 17.4K
- Earning Date
- SILO 05-12-2025
- EVGN 03-06-2025
- Dividend Yield
- SILO N/A
- EVGN N/A
- EPS Growth
- SILO N/A
- EVGN N/A
- EPS
- SILO N/A
- EVGN N/A
- Revenue
- SILO $72,102.00
- EVGN $8,511,000.00
- Revenue This Year
- SILO $1.86
- EVGN $74.97
- Revenue Next Year
- SILO N/A
- EVGN $78.26
- P/E Ratio
- SILO N/A
- EVGN N/A
- Revenue Growth
- SILO N/A
- EVGN 50.90
- 52 Week Low
- SILO $0.77
- EVGN $1.20
- 52 Week High
- SILO $4.50
- EVGN $9.00
- Technical
- Relative Strength Index (RSI)
- SILO 28.08
- EVGN 36.50
- Support Level
- SILO $1.20
- EVGN $1.32
- Resistance Level
- SILO $1.39
- EVGN $1.38
- Average True Range (ATR)
- SILO 0.09
- EVGN 0.07
- MACD
- SILO -0.02
- EVGN -0.01
- Stochastic Oscillator
- SILO 0.00
- EVGN 18.52
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.